If you want to know Bionaturis’ latest news, here you are our October Newsletter

Imagen Bionaturis Newsletter


  • “BioSpain 2014 has confirmed our position in the sector”
  • Bionaturis holds the Technical Comitee of SNC-Integra project
  • Bionaturis attends CPhI in Paris

Let’s get to know…

Ainhoa Alzualde Zuloaga, 37 years old, born in Donostia, PhD in Biological Sciences at Basque Country University/EHU.



Ainhoa Alzualde

  • -When you were a child, what did you want to be as an adult?
  • I think I wanted to work at a hospital, as a doctor or nurse (as my mother).
  • -What do you like the most about your job?
  • Having to learn new things and apply them in our assays. I also like the satisfaction of knowing that our customers are happy with the result.
  • -What are your future challenges?
  • Working with motivation and surrounded by a good team.
  • -Your favourite dish
  • A mushroom scramble, a large steak, grilled fish… there are so many delicious dishes…! I enjoy tasting different food.
  • -A place
  • Aralar Mountains.
  • -A film
  • ‘Seven’, by David Fincher.
  • -A historical figure
  • Albert Einstein.
  • -A book
  • ‘Tell me who I am’, by Julia Navarro
  • -A song
  • ‘Ilargia’, by Ken Zazpi.
  • -What do you usually do in your free time?
  • I have a four and a seven-year-old daughter, so my free time is for them.
  • -You can’t live without….
  • The support of my family.
  • -How do you imagine the world in 20 years?
  • I suppose in a part of the world technology will go on progressing in a frenetic rhythm and it will cause considerable social changes, some positive and others negative… I want to imagine that thanks to the human values the balance will be a positive one…
  Ainhoa has been working as Assays Manager in BBD BioPhenix (Bionaturis Group) since February, 2013.

“BioSpain 2014 has confirmed our position
in the sector”

The delegates of Bionaturis Group at BioSpain 2014 has confirmed its positioning in the sector. In just three days they hold 40 one-to-one meetings to bolster existing business relationships and starting new collaborations for the next future.“The quality and fruitfully meetings hold there demonstrate that we are in the right path. There are more and more multinational companies and institutions that are interested in working with us to move forward innovative solutions to the market. The unique features of the FLYLIFE platform to develop biological drugs and the versatility of the zebrafish animal model to optimize the drug discovery process were the hot topics during the meetings. […] Read more

Bionaturis holds the Technical Comitee of SNC-Integra project

Bionaturis has recently held the III Technical Executive Committee of the Consortium SNC_Integra, led by Laboratorios Rovi and taking part Bionaturis and other companies such as Canvax, GMV, VivaCell, Vivia Allosterics and Vivia Biotech. The project is funded by the Centre for Industrial Technological Development (CDTI, in Spanish), by the public-private cooperation program for R&D initiatives, FEDER-INNTERCONECTA. The goal of this project is obtaining, in a completely safe and efficient way, new drugs to treat pathologies related to the Central Nervous System […] Read more

Bionaturis attends CPhI
in Paris

Bionaturis’ CSO, Juan Jose Infante, has attendeded the international pharmaceutical meeting CPhI, to be held in Paris. This event gathers in each edition more than 2,000 exhibitors and 34,000 attendees from more than 140 countries all over the world, thus it is considered a must-have in your calendar of human and animal health events […] Read more



Relevant info: Financial information First Semester 2014Relevant info: on changes in the company price quotation
Hi, this newsletter contains information about my website. For any question, please contact to info@bionaturis.com
Imagen Boletín Bionaturis Imagen Twitter Bionaturis Imagen Linked In Bionaturis Imagen Flickr Bionaturis Imagen Youtube Bionaturis Imagen Blog Bionaturis


Este e-mail ha sido enviado por *|EMAIL|*¿Por qué me sale esto?    No quiero seguir recibiendo este newsletter    Actualizar las preferencias de suscripción*|LIST:ADDRESSLINE|*